Impaired Homocysteine Metabolism and Atherothrombotic Disease
- 1 May 2001
- journal article
- review article
- Published by Elsevier in Laboratory Investigation
- Vol. 81 (5), 645-672
- https://doi.org/10.1038/labinvest.3780275
Abstract
No abstract availableKeywords
This publication has 252 references indexed in Scilit:
- Vascular Complications of Severe Hyperhomocysteinemia in Patients with Homocystinuria Due to Cystathionine β-Synthase Deficiency: Effects of Homocysteine-Lowering TherapySeminars in Thrombosis and Hemostasis, 2000
- Enhancement by Homocysteine of Plasminogen Activator Inhibitor-1 Gene Expression and Secretion from Vascular Endothelial and Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2000
- Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuriaKidney International, 1999
- HOMOCYSTEINE AND VASCULAR DYSFUNCTIONLife Sciences, 1997
- Structural requirements for oxidation of low‐density lipoprotein by thiolsFEBS Letters, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Lipid peroxidation and homocysteine induced toxicityAtherosclerosis, 1994
- Homocysteine metabolism and the oxidative modification of proteins and lipidsFree Radical Biology & Medicine, 1993
- Thiyl radical attack on polyunsaturated fatty acids: A possible route to lipid peroxidationBiochemical and Biophysical Research Communications, 1989
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985